Sensory and vascular changes in a rat monoarthritis model: Prophylactic and therapeutic effects of meloxicam

Inflammation Research

Volumn 59, Issue 8, 2010, Pages 667-678

  Hashmi, Javeria Ali ^a,c,d   Yashpal, Kiran ^a,e   Holdsworth, David W ^a,b   Henry, James L ^a,e  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b ROBARTS RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e MCMASTER UNIVERSITY   (Canada)

Author keywords

Animal model; CFA; Inflammatory joint disease; Joint pain; Range of motion; Rheumatoid arthritis

Indexed keywords

MELOXICAM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANKLE EDEMA; ARTICLE; BONE REMODELING; CELL INFILTRATION; CHONDROPATHY; CONTROLLED STUDY; DRUG EFFECT; EVOKED RESPONSE; EXTRAVASATION; HISTOPATHOLOGY; IMMUNOCOMPETENT CELL; JOINT SWELLING; MALE; MONARTHRITIS; NONHUMAN; RANGE OF MOTION; RAT; SENSORY STIMULATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, EXPERIMENTAL; CYCLOOXYGENASE INHIBITORS; FREUND'S ADJUVANT; HUMANS; INFLAMMATION; MALE; RATS; RATS, SPRAGUE-DAWLEY; TARSUS, ANIMAL; THIAZINES; THIAZOLES;

EID: 77955657339     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-010-0179-3     Document Type: Article

References (62)

1. TK Kvien 2004 Epidemiology and burden of illness of rheumatoid arthritis Pharmacoeconomics 22 2 Suppl 1 1 12 15157000
2. MA Sprangers EB de Regt F Andries HM van Agt RV Bijl JB de Boer, et al. 2000 Which chronic conditions are associated with better or poorer quality of life? J Clin Epidemiol 53 9 895 907 10.1016/S0895-4356(00)00204-3 1:STN:280:DC%2BD3M%2FhtFWrtg%3D%3D 11004416
3. MA Testa DC Simonson 1996 Assessment of quality-of-life outcomes N Engl J Med 334 13 835 840 10.1056/NEJM199603283341306 1:STN:280:DyaK287ns1akug%3D%3D 8596551
4. T Uhlig JH Loge IS Kristiansen TK Kvien 2007 Quantification of reduced health-related quality of life in patients with rheumatoid arthritis compared to the general population J Rheumatol 34 6 1241 1247 17516624
5. EM Badley GK Webster I Rasooly 1995 The impact of musculoskeletal disorders in the population: are they just aches and pains? Findings from the 1990 Ontario Health Survey J Rheumatol 22 4 733 739 1:STN:280: DyaK2MzhtFalug%3D%3D 7791173
6. B Fautrel F Guillemin 2002 Cost of illness studies in rheumatic diseases Curr Opin Rheumatol 14 2 121 126 10.1097/00002281-200203000-00008 11845016
7. AM Chorus HS Miedema A Boonen LS Van Der 2003 Quality of life and work in patients with rheumatoid arthritis and ankylosing spondylitis of working age Ann Rheum Dis 62 12 1178 1184 10.1136/ard.2002.004861 1:STN:280: DC%2BD3srpsFGlsw%3D%3D 14644855
8. KH Sousa E Ryu OM Kwok SW Cook SG West 2007 Development of a model to measure symptom status in persons living with rheumatoid arthritis Nurs Res 56 6 434 440 10.1097/01.NNR.0000299850.29558.db 18004190
9. U Kalyoncu M Dougados JP Daures L Gossec 2008 Reporting of patient-reported outcomes in recent trials in rheumatoid arthritis: a systematic literature review Ann Rheum Dis 68 183 190 10.1136/ard.2007.084848 18375533
10. JF Fries P Spitz RG Kraines HR Holman 1980 Measurement of patient outcome in arthritis Arthritis Rheum 23 2 137 145 10.1002/art.1780230202 1:STN:280:DyaL3c7ltlGlsQ%3D%3D 7362664
11. T Sokka A Kankainen P Hannonen 2000 Scores for functional disability in patients with rheumatoid arthritis are correlated at higher levels with pain scores than with radiographic scores Arthritis Rheum 43 2 386 389 10.1002/1529-0131(200002)43:2<386::AID-ANR19>3.0.CO;2-Z 1:STN:280:DC%2BD3c7lsFGntA%3D%3D 10693879
12. RF Meenan EH Yelin CJ Henke DL Curtis WV Epstein 1978 The costs of rheumatoid arthritis. A patient-oriented study of chronic disease costs Arthritis Rheum 21 7 827 833 10.1002/art.1780210714 1:STN:280: DyaE1M%2FitFajtQ%3D%3D 100122
13. KM Pugner DI Scott JW Holmes K Hieke 2000 The costs of rheumatoid arthritis: an international long-term view Semin Arthritis Rheum 29 5 305 320 10.1016/S0049-0172(00)80017-7 1:STN:280:DC%2BD3c3mtlWjtw%3D%3D 10805355
14. E Yelin 1996 The costs of rheumatoid arthritis: absolute, incremental, and marginal estimates J Rheumatol Suppl 44 47 51 1:STN:280:DyaK28vivF2jsA%3D%3D 8833052
15. G Kobelt K Eberhardt L Jonsson B Jonsson 1999 Economic consequences of the progression of rheumatoid arthritis in Sweden Arthritis Rheum 42 2 347 356 10.1002/1529-0131(199902)42:2<347::AID-ANR18>3.0.CO;2-P 1:STN:280:DyaK1M7kvVOqtQ%3D%3D 10025930
16. B Fautrel AE Clarke F Guillemin V Adam Y St-Pierre T Panaritis, et al. 2007 Costs of rheumatoid arthritis: new estimates from the human capital method and comparison to the willingness-to-pay method Med Decis Making 27 2 138 150 10.1177/0272989X06297389 17409364
17. M Chen E Boilard PA Nigrovic P Clark D Xu GA Fitzgerald, et al. 2008 Predominance of cyclooxygenase 1 over cyclooxygenase 2 in the generation of proinflammatory prostaglandins in autoantibody-driven K/BxN serum-transfer arthritis Arthritis Rheum 58 5 1354 1365 10.1002/art.23453 1:CAS:528: DC%2BD1cXms1ehu7c%3D 18438856
18. A Hernanz ME De N Romera C Perez-Ayala J Gijon F Arnalich 1993 Calcitonin gene-related peptide II, substance P and vasoactive intestinal peptide in plasma and synovial fluid from patients with inflammatory joint disease Br J Rheumatol 32 1 31 35 10.1093/rheumatology/32.1.31 1:STN:280:DyaK3s7js1ynsw%3D%3D 7678534
19. J Larsson A Ekblom K Henriksson T Lundeberg E Theodorsson 1991 Concentration of substance P, neurokinin A, calcitonin gene-related peptide, neuropeptide Y and vasoactive intestinal polypeptide in synovial fluid from knee joints in patients suffering from rheumatoid arthritis Scand J Rheumatol 20 5 326 335 10.3109/03009749109096808 1:STN:280:DyaK38%2FlsVeksA%3D%3D 1947895
20. S Averill JJ Inglis VR King SW Thompson WB Cafferty PJ Shortland, et al. 2008 Reg-2 expression in dorsal root ganglion neurons after adjuvant-induced monoarthritis Neuroscience 155 4 1227 1236 10.1016/j.neuroscience.2008.06.049 1:CAS:528:DC%2BD1cXhtVKlsLfF 18652880
21. DG Bulling D Kelly S Bond DS McQueen JR Seckl 2001 Adjuvant-induced joint inflammation causes very rapid transcription of beta-preprotachykinin and alpha-CGRP genes in innervating sensory ganglia J Neurochem 77 2 372 382 10.1046/j.1471-4159.2001.00175.x 1:CAS:528:DC%2BD3MXjtVOlurw%3D 11299299
22. E Dowd DS McQueen IP Chessell PP Humphrey 1998 P2X receptor-mediated excitation of nociceptive afferents in the normal and arthritic rat knee joint Br J Pharmacol 125 2 341 346 10.1038/sj.bjp.0702080 1:CAS:528:DyaK1cXmtlClurg%3D 9786507
23. KJ Bar G Natura A Telleria-Diaz P Teschner R Vogel E Vasquez, et al. 2004 Changes in the effect of spinal prostaglandin E2 during inflammation: prostaglandin E (EP1-EP4) receptors in spinal nociceptive processing of input from the normal or inflamed knee joint J Neurosci 24 3 642 651 10.1523/JNEUROSCI.0882-03.2004 14736850
24. M Fang Y Wang HX Liu XS Liu JS Han 2000 Decreased GDNF mRNA expression in dorsal spinal cord of unilateral arthritic rat Neuroreport 11 4 737 741 10.1097/00001756-200003200-00017 1:CAS:528:DC%2BD3cXisVKht7k%3D 10757511
25. NR Sharif CM Cahill A Ribeiro-da-Silva HA Menard JL Henry 2005 Remodelling of spinal nociceptive mechanisms in an animal model of monoarthritis Eur J Neurosci 22 8 2005 2015 10.1111/j.1460-9568.2005.04382.x
26. L Djouhri SN Lawson 2001 Increased conduction velocity of nociceptive primary afferent neurons during unilateral hindlimb inflammation in the anaesthetised guinea-pig Neuroscience 102 3 669 679 10.1016/S0306-4522(00)00503- 0 1:CAS:528:DC%2BD3MXhsVKlsr0%3D 11226703
27. L Djouhri S Koutsikou X Fang S McMullan SN Lawson 2006 Spontaneous pain, both neuropathic and inflammatory, is related to frequency of spontaneous firing in intact C-fiber nociceptors J Neurosci 26 4 1281 1292 10.1523/JNEUROSCI.3388- 05.2006 1:CAS:528:DC%2BD28XhsVSjtrY%3D 16436616
28. F Beiche S Scheuerer K Brune G Geisslinger M Goppelt-Struebe 1996 Up-regulation of cyclooxygenase-2 mRNA in the rat spinal cord following peripheral inflammation FEBS Lett 390 2 165 169 10.1016/0014-5793(96)00604-7 1:CAS:528:DyaK28XkvVCru74%3D 8706851
29. MacDonald TM, Pettitt D, Lee FH, Schwartz JS. Channelling of patients taking NSAIDs or cyclooxygenase-2-specific inhibitors and its effect on interpretation of outcomes. Rheumatology (Oxford) 2003 Nov;42 Suppl 3:iii3-10.
30. K Johnell J Fastbom 2008 Concomitant use of gastroprotective drugs among elderly NSAID/COX-2 selective inhibitor users: a nationwide register-based study Clin Drug Investig 28 11 687 695 10.2165/00044011-200828110-00002 1:CAS:528:DC%2BD1cXhtlKqsr7E 18840011
31. JM Laird JF Herrero RP Garcia de la F Cervero 1997 Analgesic activity of the novel COX-2 preferring NSAID, meloxicam in mono-arthritic rats: central and peripheral components Inflamm Res 46 6 203 210 10.1007/s000110050174 1:STN:280:DyaK2szoslamtQ%3D%3D 9243303
32. FF Lam HH Wong ES Ng 2004 Time course and substance P effects on the vascular and morphological changes in adjuvant-induced monoarthritic rats Int Immunopharmacol 4 2 299 310 10.1016/j.intimp.2004.01.009 1:CAS:528: DC%2BD2cXhslSkt7o%3D 14996421
33. VL Kumar S Roy R Sehgal BM Padhy 2006 A comparative study on the efficacy of rofecoxib in monoarticular arthritis induced by latex of Calotropis procera and Freund's complete adjuvant Inflammopharmacol 14 1-2 17 21 10.1007/s10787-006-1512-x 1:CAS:528:DC%2BD28XkvF2ltLs%3D
34. SH Butler F Godefroy JM Besson J Weil-Fugazza 1992 A limited arthritic model for chronic pain studies in the rat Pain 48 1 73 81 10.1016/0304-3959(92) 90133-V 1:STN:280:DyaK387ltVSqug%3D%3D 1738577
35. GM Pitcher J Ritchie JL Henry 1999 Paw withdrawal threshold in the von Frey hair test is influenced by the surface on which the rat stands J Neurosci Methods 87 2 185 193 10.1016/S0165-0270(99)00004-7 1:STN:280: DC%2BD3MzjvFKmsQ%3D%3D 11230815
36. CM Pearson 1963 Experimental joint disease observations on adjuvant-induced arthritis J Chronic Dis 16 863 874 10.1016/0021-9681(63)90136-X 1:STN:280:DyaF2c%2Fhs1Shsw%3D%3D 14058394
37. H Vermeirsch R Biermans PL Salmon TF Meert 2007 Evaluation of pain behavior and bone destruction in two arthritic models in guinea pig and rat Pharmacol Biochem Behav 87 3 349 359 10.1016/j.pbb.2007.05.010 1:CAS:528:DC%2BD2sXotlWlt7s%3D 17583780
38. AW Wilson SJ Medhurst CI Dixon NC Bontoft LA Winyard KT Brackenborough, et al. 2006 An animal model of chronic inflammatory pain: pharmacological and temporal differentiation from acute models Eur J Pain 10 6 537 549 10.1016/j.ejpain.2005.08.003 1:CAS:528:DC%2BD28Xms1els78%3D 16199187
39. GW Cannon S Openshaw F Clayton AD Sawitzke MM Griffiths 1999 Adjuvant arthritis in rats: susceptibility to arthritis induced by Mycobacterium butyricum and Mycobacterium tuberculosis Transplant Proc 31 3 1590 1591 10.1016/S0041-1345(99)00049-4 1:STN:280:DyaK1M3mtFequg%3D%3D 10331013
40. GW Cannon ML Woods F Clayton MM Griffiths 1993 Induction of arthritis in DA rats by incomplete Freund's adjuvant J Rheumatol 20 1 7 11 1:STN:280:DyaK3s7otVWktA%3D%3D 8441169
41. AC Issekutz JY Mu G Liu J Melrose EL Berg 2001 E-selectin, but not P-selectin, is required for development of adjuvant-induced arthritis in the rat Arthritis Rheum 44 6 1428 1437 10.1002/1529-0131(200106)44:6<1428::AID- ART238>3.0.CO;2-U 1:CAS:528:DC%2BD38Xps1Q%3D 11407705
42. T Haak M Delverdier MF Amardeilh IP Oswald PL Toutain 1996 Pathologic study of an experimental canine arthritis induced with Complete Freund's Adjuvant Clin Exp Rheumatol 14 6 633 641 1:STN:280:DyaK2s7jtlGlsQ%3D%3D 8978958
43. Weinblatt ME. Rheumatoid arthritis in 2003: where are we now with treatment? Ann Rheum Dis 2003 Nov;62 Suppl 2:ii94-ii96.
44. R Holmdahl JC Lorentzen S Lu P Olofsson L Wester J Holmberg, et al. 2001 Arthritis induced in rats with nonimmunogenic adjuvants as models for rheumatoid arthritis Immunol Rev 184 184 202 10.1034/j.1600-065x.2001.1840117.x 1:CAS:528:DC%2BD38XitVSgs7k%3D 12086312
45. B Calvino MO Crepon-Bernard BD Le 1987 Parallel clinical and behavioural studies of adjuvant-induced arthritis in the rat: possible relationship with 'chronic pain' Behav Brain Res 24 1 11 29 10.1016/0166-4328(87)90032-5 1:STN:280:DyaL2s3htlGqtg%3D%3D 3580112
46. F Godefroy J Weil-Fugazza JM Besson 1987 Complex temporal changes in 5-hydroxytryptamine synthesis in the central nervous system induced by experimental polyarthritis in the rat Pain 28 2 223 238 10.1016/0304-3959(87) 90118-7 1:CAS:528:DyaL2sXhvFCisrY%3D 3822505
47. H Reiber AJ Suckling MG Rumsby 1984 The effect of Freund's adjuvants on blood-cerebrospinal fluid barrier permeability J Neurol Sci 63 1 55 61 10.1016/0022-510X(84)90108-4 1:CAS:528:DyaL2cXhtlOiurk%3D 6699654
48. MJ Millan A Czlonkowski B Morris C Stein R Arendt A Huber, et al. 1988 Inflammation of the hind limb as a model of unilateral, localized pain: influence on multiple opioid systems in the spinal cord of the rat Pain 35 3 299 312 10.1016/0304-3959(88)90140-6 1:STN:280:DyaL1M7ksVKhsw%3D%3D 2906425
49. C Stein MJ Millan A Herz 1988 Unilateral inflammation of the hindpaw in rats as a model of prolonged noxious stimulation: alterations in behavior and nociceptive thresholds Pharmacol Biochem Behav 31 2 445 451 10.1016/0091- 3057(88)90372-3
50. LF Donaldson JR Seckl DS McQueen 1993 A discrete adjuvant-induced monoarthritis in the rat: effects of adjuvant dose J Neurosci Methods 49 1-2 5 10 10.1016/0165-0270(93)90103-X 1:STN:280:DyaK2c%2FpslSitA%3D%3D 8271831
51. Y Nagakura M Okada A Kohara T Kiso T Toya A Iwai, et al. 2003 Allodynia and hyperalgesia in adjuvant-induced arthritic rats: time course of progression and efficacy of analgesics J Pharmacol Exp Ther 306 2 490 497 10.1124/jpet.103.050781 1:CAS:528:DC%2BD3sXlslGltLg%3D 12730275
52. JJ Inglis CA Notley D Essex AW Wilson M Feldmann P Anand, et al. 2007 Collagen-induced arthritis as a model of hyperalgesia: functional and cellular analysis of the analgesic actions of tumor necrosis factor blockade Arthritis Rheum 56 12 4015 4023 10.1002/art.23063 18050216
53. Y Lu TA McNearney SP Wilson DC Yeomans KN Westlund 2008 Joint capsule treatment with enkephalin-encoding HSV-1 recombinant vector reduces inflammatory damage and behavioural sequelae in rat CFA monoarthritis Eur J Neurosci 27 5 1153 1165 10.1111/j.1460-9568.2008.06076.x 18364035
54. PG Conaghan P O'Connor D McGonagle P Astin RJ Wakefield WW Gibbon, et al. 2003 Elucidation of the relationship between synovitis and bone damage: a randomized magnetic resonance imaging study of individual joints in patients with early rheumatoid arthritis Arthritis Rheum 48 1 64 71 10.1002/art.10747 12528105
55. Gravallese EM. Bone destruction in arthritis. Ann Rheum Dis 2002 Nov;61 Suppl 2:ii84-ii86.
56. JT Halla JG Hardin S Fallahi 1987 The nature of the onset of rheumatoid arthritis: a reassessment Rheumatol Int 7 4 169 171 10.1007/BF00270365 1:STN:280:DyaL1c%2Fkt1Cqsw%3D%3D 3671990
57. JT Halla V Hirsch 1987 Monoarthritis as the presenting manifestation of localized Ewing's sarcoma in an older patient J Rheumatol 14 3 628 631 1:STN:280:DyaL2szhtFGjuw%3D%3D 3625649
58. AT Masi 1983 Articular patterns in the early course of rheumatoid arthritis Am J Med 75 6A 16 26 10.1016/0002-9343(83)90471-0 1:STN:280: DyaL2c7gtFGitg%3D%3D 6660237
59. Hazes JM. Determinants of physical function in rheumatoid arthritis: association with the disease process. Rheumatology (Oxford) 2003 May;42 Suppl 2:ii17-ii21.
60. G Engelhardt D Homma K Schlegel R Utzmann C Schnitzler 1995 Anti-inflammatory, analgesic, antipyretic and related properties of meloxicam, a new non-steroidal anti-inflammatory agent with favourable gastrointestinal tolerance Inflamm Res 44 10 423 433 10.1007/BF01757699 1:CAS:528: DyaK2MXptVKgt7w%3D 8564518
61. DE Furst KS Kolba R Fleischmann J Silverfield M Greenwald S Roth, et al. 2002 Dose response and safety study of meloxicam up to 22.5 mg daily in rheumatoid arthritis: a 12 week multicenter, double blind, dose response study versus placebo and diclofenac J Rheumatol 29 3 436 446 1:CAS:528: DC%2BD38XisVWlsbY%3D 11908554
62. K Omote T Kawamata Y Nakayama H Yamamoto M Kawamata A Namiki 2002 Effects of a novel selective agonist for prostaglandin receptor subtype EP4 on hyperalgesia and inflammation in monoarthritic model Anesthesiology 97 1 170 176 10.1097/00000542-200207000-00024 1:CAS:528:DC%2BD38XlslSqtbY%3D 12131119